Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$69.25BHealthcare Market cap, Sector
PTC Therapeutics
PTCT$6.55BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 PTCT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsPTCT
84B
D57
87A
F35
92A
C63
66C
C62
75B
F4
91A
D55
95A
D57
Side-by-side metrics
| Metric | JSLL.NS | PTCT |
|---|---|---|
| Market cap | Winner: $69.25B | $6.55B |
| P/E (TTM) | 33.3x | - Winner |
| EV/EBIT | 24.1x | 6.2x Winner |
| ROIC (TTM) | Winner: 39.15% | -2.38% |
| Gross margin | Winner: 88.58% | 77.84% |
| Net margin | Winner: 27.68% | -22.58% |
| Revenue CAGR 5y | Winner: 57.81% | 33.89% |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | 0.3x | - Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Net margin27.68%vs -22.58%+182%
- ROIC (TTM)39.15%vs -2.38%+106%
- Market cap$69.25Bvs $6.55B+91%
- Revenue CAGR 5y57.81%vs 33.89%+41%
PTCT leads on
- P/E (TTM)-vs 33.3x+193%
- Debt / Equity-vs 0.3x+112%
- EV/EBIT6.2xvs 24.1x+74%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.